J. Vainshtein

发表

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

H. Sandler, D. Hamstra, C. Pan, 2012, Radiation Oncology.

Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.

K. Wong, A. Eisbruch, T. Carey, 2014, Oral oncology.

Comparison of intensity modulated radiation therapy (IMRT) with conventional radiotherapy (CRT) for cervical cancer with concurrent cisplatin (CDDP)

R. Yaparpalvi, S. Kalnicki, R. Hannan, 2008 .

Investigating the clinical significance of body composition changes in patients undergoing chemoradiation for oropharyngeal cancer using analytic morphomics

Patrick E. Rabban, S. Jolly, A. Eisbruch, 2016, SpringerPlus.

Outcomes and prognostic factors in modern era management of major salivary gland cancer.

K. Magliocca, K. Higgins, D. Marcus, 2015, Oral oncology.

Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States

J. Griggs, M. Banerjee, R. Jagsi, 2017, The Laryngoscope.

Matted nodes as a predictor of distant metastasis in advanced‐stage III/IV oropharyngeal squamous cell carcinoma

A. Eisbruch, T. Carey, C. Bradford, 2016, Head & neck.

Impact of xerostomia on dysphagia after chemotherapy–intensity‐modulated radiotherapy for oropharyngeal cancer: Prospective longitudinal study

M. Schipper, A. Eisbruch, Teresa H. Lyden, 2016, Head & neck.

Long-Term Quality of Life After Swallowing and Salivary sparing Chemo-IMRT in survivors of HPV-related Oropharyngeal Cancer

J. Vainshtein, D. Moon, 2015 .

Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy.

M. Schipper, A. Eisbruch, J. Mchugh, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.

F. Feng, A. Eisbruch, D. Chepeha, 2015, International journal of radiation oncology, biology, physics.

Human papillomavirus–related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor

A. Eisbruch, T. Carey, C. Bradford, 2015, Head & neck.

Head and neck squamous cell carcinoma of unknown primary: Neck dissection and radiotherapy or definitive radiotherapy

M. Schipper, A. Eisbruch, C. Bradford, 2014, Head & neck.

Response from authors of "reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer".

A. Eisbruch, J. Vainshtein, 2014, Oral oncology.

Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy

F. Feng, M. Schipper, D. Hamstra, 2016, American journal of clinical oncology.

Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study.

R. Abrams, I. Francis, M. Schipper, 2013, International journal of radiation oncology, biology, physics.

Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer

C. Bradford, G. Wolf, F. Worden, 2013, Expert review of anticancer therapy.

Function, muscles, and sparing by IMRT for head-and-neck cancer.

A. Eisbruch, J. Vainshtein, 2013, International journal of radiation oncology, biology, physics.

Dose Constraint Recommendations and a Predictive Nomogram of Incidence of Hematological Toxicity for Cervix Cancer Patients Treated with Concurrent Cisplatin and Intensity Modulated Radiation Therapy (IMRT)

K. Mehta, R. Yaparpalvi, S. Kalnicki, 2008 .

Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.

K. Wong, A. Eisbruch, T. Carey, 2014, Oral oncology.

Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.

K. Mehta, C. Guha, J. Roy-Chowdhury, 2014, International journal of radiation oncology, biology, physics.

Neurologic late effects associated with radiologic evidence of vertebral osteoradionecrosis after salvage laryngectomy: A syndrome associated with survivors of laryngeal and hypopharyngeal cancer

A. Eisbruch, C. Bradford, D. Chepeha, 2016, Head & neck.

Matted nodes: High distant‐metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus–related oropharyngeal cancer

A. Eisbruch, T. Carey, C. Bradford, 2016, Head & neck.

Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy

G. Merrick, P. McLaughlin, D. Hamstra, 2016, American journal of clinical oncology.

Phase I study of ON 01910.Na, a novel polo-like kinase 1 pathway modulator, administered as a weekly 24-hour continuous infusion in patients with advanced cancer

Manoj Kumar, S. Mani, S. Goel, 2008 .

Long‐term neck and shoulder function among survivors of oropharyngeal squamous cell carcinoma treated with chemoradiation as assessed with the neck dissection impairment index

A. Pearson, A. Eisbruch, C. Bradford, 2021, Head & neck.

Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy.

W. Jackson, F. Feng, D. Hamstra, 2014, Practical radiation oncology.

Outcomes following temporalis tendon transfer in irradiated patients.

J. Vainshtein, Garrett R. Griffin, Jennifer C. Kim, 2012, Archives of facial plastic surgery.

The interval to biochemical failure is prognostic for metastasis, prostate cancer-specific mortality, and overall mortality after salvage radiation therapy for prostate cancer.

W. Jackson, F. Feng, D. Hamstra, 2013, International journal of radiation oncology, biology, physics.

Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapy.

Daniel A Hamstra, G. Merrick, P. McLaughlin, 2013, International journal of radiation oncology, biology, physics.

Patient-reported voice and speech outcomes after whole-neck intensity modulated radiation therapy and chemotherapy for oropharyngeal cancer: prospective longitudinal study.

K. Griffith, F. Feng, K. Vineberg, 2014, International journal of radiation oncology, biology, physics.

Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy

M. Schipper, T. Lawrence, Jincheng Shen, 2017, American Journal of Clinical Oncology.

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

H. Sandler, D. Hamstra, C. Pan, 2012, Radiation oncology.

Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy

G. Merrick, D. Hamstra, J. Vainshtein, 2016, American journal of clinical oncology.